Imbruvica is a medication used to treat certain types of B-cell cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenstrom's macroglobulinemia. It is an oral medication that works by blocking a protein called Bruton's tyrosine kinase (BTK), which helps cancer cells survive and multiply.
Here are 10 important things to know about Imbruvica:
- Imbruvica is FDA-approved for the treatment of several types of B-cell cancers, including CLL, MCL, and Waldenstrom's macroglobulinemia.
- It is usually taken once daily, with or without food, and should be swallowed whole with a glass of water.
- Common side effects of Imbruvica include diarrhea, fatigue, nausea, bruising, and muscle pain.
- Imbruvica can interact with certain medications, so it is important to tell your doctor about all the medications you are taking before starting treatment.
- It is important to follow your doctor's instructions carefully when taking Imbruvica, as missing doses or taking too much can affect how well the medication works.
- Imbruvica may cause changes in blood cell counts, so your doctor will monitor your blood regularly during treatment.
- If you experience any severe or persistent side effects while taking Imbruvica, such as bleeding, infection, or shortness of breath, contact your doctor immediately.
- Imbruvica is not recommended for use during pregnancy, as it may harm the unborn baby. Use effective birth control while taking this medication.
- It is important to store Imbruvica at room temperature, away from moisture and heat, and to keep it out of the reach of children.
- Imbruvica can be a life-saving treatment for many people with B-cell cancers, but it is important to work closely with your healthcare team to manage any side effects and ensure the best possible outcome.